(Source: Datamonitor)
CVS Caremark, a provider of prescriptions and related healthcare services, has reported net earnings available to common shareholders of $1.02 billion, or $0.71 per diluted share, for the third quarter ended September 30, 2009, compared to $732.5 million, or $0.5 per diluted share, in the third quarter of 2008.
For the third quarter of 2009, net revenues were $24.64 billion, up 18.1%, compared to $20.86 billion for the third quarter of 2008.
For the first nine months of 2009, net revenues were $72.91 billion, compared to $63.33 billion in the same period of 2008. Net earnings available to common shareholders were $2.65 billion, or $1.81 per diluted share, compared to $2.25 billion, or $1.54 per diluted share, in the corresponding period of 2008.
Tom Ryan, chairman, president and CEO of CVS Caremark, said: "I'm very pleased with our performance across the enterprise this quarter. The quarter was characterized by continued industry-leading performance in our retail business, solid performance in our pharmacy benefit management, and record results from MinuteClinic. Our integrated pharmacy care offerings are contributing to results across the company at a growing pace."
A service of YellowBrix, Inc.
